【研討會訊息- 第3屆 NHRI-ToMMo Conference】
▶本活動提供-公務人員終身學習時數(需具公務人員資格) 歡迎踴躍報名參加，謝謝!
「國家衛生研究院-論壇」訂於106年11月2日至3日假張榮發基金會國際會議中心舉辦第3屆 NHRI-ToMMo Conference，本次會議邀請台、日、美、港genimics、biobanking及LHS專家學者來台演講，藉以促進國際學術交流，提升國內精準醫療及LHS研究水準。本屆會議共邀請4位日本專家、3位美國專家及1位香港專家蒞會演講，並邀請國內學者專家共襄盛舉。
「本活動相關資訊」：
會議議程：https://goo.gl/S1zQUn
報名網址：https://goo.gl/dS3xoL
報名時間：即日起至2017/10/29 截止
完整訊息：https://goo.gl/8UiQKi
Session 1: Cohort Studies – Speaker
Charles B. Brendler
【Evolution of Cancer Care: From Traditional to Personalized to Precise】
Charles B. Brendler, M.D.
NorthShore University HealthSystem, U.S.A.
Cancer care has rapidly evolved from a traditional “one size fits all” approach to an era of precision medicine that is individualized and genomic-based. Over the past decade, our institution has embraced this change, moving first from a model of traditional, physician-directed cancer care to one of “personalized” care that is multidisciplinary, integrated,and involves our patients in the decision-making process. In now transitioning from personalized to precision (genomic-based) cancer care, our approach differs from that of most institutions which focuses on tumor (somatic) DNA alterations in cancer patients; while important, this approach benefits only those patients already diagnosed with cancer and is most often directed at those with late stage disease with the goals of palliating and prolonging life. In contrast, we have focused primarily on hereditary (genomic) DNA profiles in order to optimize cancer care across the entire spectrum of disease, using genetic risk assessment to individualize cancer screening, prevention, and diagnostic strategies. With this approach, our goal is to target care at those at increased risk of both developing and dying of cancer, thereby reducing cancer deaths and decreasing over-diagnosis and unnecessary treatment.
risk assessment model 在 Risk assessment - Wikipedia 的相關結果
Put in simpler terms, a risk assessment determines possible mishaps, their likelihood and consequences, and the tolerances for such events. ... <看更多>